Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Edurant, rilpivirine (TMC278)
print preview
bookmark
share with colleague
General Information
Company
Johnson & Johnson
Description
Diarylpyrimidine non-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target
DNA polymerase
Mechanism of Action
Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Latest Stage of Development
Approved
Indication
HIV / AIDS
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy